Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cardiovascular pathology

Shin WS, Szuba A, Rockson SG. The role of chemokines in human cardiovascular pathology enhanced biological insights. Atherosclerosis 2002 160(1) 91-102. [Pg.229]

The effects of phenytoin on the cardiovascular system vary with the dose, the mode and rate of administration, and any cardiovascular pathology. Rapid administration can produce transient hypotension that is the combined result of peripheral vasodilation and depression of myocardial contractility. These effects are due to direct actions of phenytoin on the vascular bed and ventricular myocardium. If large doses are given slowly, dose-related decreases in left ventricular force, rate of force development, and cardiac output can be observed, along with an increase in left ventricular end-diastolic pressure. [Pg.178]

Cerebrovascular and Cardiovascular Pathology in Alzheimer s Disease Jack C. de la Torre... [Pg.463]

A nonfunctional MTP gene/protein causes ABL.What are the possible affects on lipid levels and cardiovascular pathology if this protein is overexpressed ... [Pg.299]

Isoquinoline derivatives, (VI), effective as protein kinase inhibitors were prepared by Livnah (7) and used in treating cardiovascular pathologies. [Pg.290]

In addition to various plasma lipids and lipoprotein species, other markers of cardiovascular disease and atherosclerosis are now considered as potent screening tools to predict these diseases. These markers are mostly related to the discoveries that a low-level chronic inflammation and related disorders of the immune system are as much, and probably more, of a clinical predictor of cardiovascular pathology than dietary fat and associated lipoproteins (165). [Pg.634]

Libby P, Schoenbeck U, Mach F, et al. Current concepts in cardiovascular pathology The role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998 104 14-188. [Pg.451]

Drug SR33557 236, possessing calcium channel blocking activity and of interest in the treatment of cardiovascular pathologies, has been prepared in a six-step synthesis in an overall 3.8% yield starting from sodium [ C]cyanide (equation 98). [Pg.1192]

Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007 75 291-302. [Pg.407]

Q-3 fatty acids lower blood pressure, improve lipids and reduce other cardiovascular disease risk factors [83]. Polyunsaturated fatty acids (PUFA) of the co-3 or eo-6 series have the potential to regulate serum triglycerides and cholesterol levels that are considered important risk factors in cardiovascular pathologies. [Pg.894]

Greaves, P. 2000. Patterns of cardiovascular pathology induced by diverse cardioactive drugs. Toxicology Letters 112-113 547-552. [Pg.156]

If there are moderate symptoms, no prominent cardiovascular pathologies, no concomitant seizure disorder, and the patient is not suicidal... [Pg.224]

Vast knowledge of the cardiovascular pathology brought about by hypertension exists in medical literature, and progressive efforts are being made to reduce the relative risks by BP control in populations. Although these efforts have been quite successful in reducing stroke, hypertensive heart and kidney diseases still represent a major cause of... [Pg.1067]

An even more precise tool is the use of receptor antagonists. In this respect the evaluation of the role of histamine is particularly instructive. Histamine was clearly recognised as a mediator of tissue injury by Sir Thomas Lewis in his classical triple response studies. This is the case now with respect to leukotrienes and thromboxane in immunological and cardiovascular pathology. But in order for histamine to be... [Pg.238]

Inborn errors of metabolism should be considered in children with cardiovascular pathology as well. Cardiac insufficiency in child with cardiomyopathy and/or arrhythmia, acute life-threatening episodes (ALTE), or sudden infant... [Pg.49]

The central role played by ACE in cardiovascular pathologies such as hypertension and cardiac hypertrophy is well established. The action of ACE as the major mechanism in the biosynthesis of angiotensin II (Angll) has made it an excellent target for therapeutic intervention in the treatment of cardiovascular diseases [4]. While a number of ACE inhibitors have been developed and used effectively... [Pg.21]

Sider, K.L., et al. Evaluation of a porcine model of early aortic valve sclerosis. Cardiovascular Pathology 23(5), 289-297 (2014)... [Pg.257]

Holliday-Ankeny, C.J., et al. The function of shear-responsive and side-dependent microRNA-486-5p in aortic valve endothelium. Cardiovascular Pathology 22(3), e50... [Pg.262]

Wong. B.W.. Wong. D., and McManus, B.M. (2002) Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes melhtus, and transplant vascular disease. Cardiovascular Pathology, 11, 332-338. [Pg.146]

Helmus, M. N., Introduction/general perspective, Frontiers of Industrial Research, International Society for Applied Cardiovascular Biology, (Abstract), Cardiovascular Pathology 7(5) 281 (1998). [Pg.338]

Marker, L.A., Ratner, B.D. and Didisheim, P. (eds) (1993) Cardiovascular Biomaterials and Biocompatibility A Guide to the Study of Blood-Tissue-Material Interactions, Cardiovascular Pathology, 2 (3 Suppl), 1S-224S. [Pg.498]


See other pages where Cardiovascular pathology is mentioned: [Pg.63]    [Pg.159]    [Pg.918]    [Pg.381]    [Pg.919]    [Pg.389]    [Pg.411]    [Pg.312]    [Pg.1192]    [Pg.200]    [Pg.616]    [Pg.2449]    [Pg.235]    [Pg.251]    [Pg.501]    [Pg.453]    [Pg.136]    [Pg.1847]    [Pg.1058]    [Pg.168]    [Pg.168]    [Pg.729]    [Pg.595]   
See also in sourсe #XX -- [ Pg.595 ]




SEARCH



Pathologic

Pathological

© 2024 chempedia.info